Lyra Therapeutics (LYRA) Preferred Shares Issued (2020)
Quarterly Preferred Shares Issued changed N/A to $30.4 million in Q1 2020 from the year-ago period, while the trailing twelve-month figure was $30.4 million through Dec 2020, changed N/A year-over-year, with the annual reading at $30.4 million for FY2020, N/A changed from the prior year.
Lyra Therapeutics' Preferred Shares Issued history spans 1 years, with the latest figure at $30.4 million for Q1 2020.
- Preferred Shares Issued came in at $30.4 million for Q1 2020.
- In the past five years, Preferred Shares Issued ranged from a high of $30.4 million in Q1 2020 to a low of $30.4 million in Q1 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | - |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | - |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | - |
| 10 | Lyra Therapeutics | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | 30.39 Mn |
| Mar 31, 2020 | 30.39 Mn |